Accelerating transporter drug discovery

Accelerating transporter drug discovery

SB Drug Discovery is excited to announce a significant advancement in its screening capabilities with the integration of the state-of-the-art SURFE2R 96SE. Enabling high throughput solid supported membrane-based electrophysiology and supporting critical lead...
NuChem Sciences Acquisition

NuChem Sciences Acquisition

Sygnature Discovery accelerates global growth with major North American acquisition. Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations,...
Sygnature acquisition

Sygnature acquisition

SYGNATURE DISCOVERY COMPLETES ACQUISITION OF SB DRUG DISCOVERY TO FURTHER STRENGTHEN THEIR MARKET-LEADING CAPABILITIES SB Drug Discovery is excited to announce that it has been acquired by Sygnature Discovery (Sygnature), a world leading integrated drug discovery...
Skip to content